Latest filing published 07 Mar 2022 for Pacira BioSciences, Inc., €68k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of John P. Phd Longenecker in Pacira BioSciences, Inc., where the filings describe the role as board member. The record holds 3 filings, for trades running from 12 January 2016 to 3 March 2022.
On the market, this insider has only ever bought: 1 purchase. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 1 option exercise.
The latest filing, published on 7 March 2022, reports an option exercise of €68k in Pacira BioSciences, Inc. The last purchase on record was published on 14 January 2016, which is 3,930 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations